glp-1 and liver disease Effects of receptor agonists on the degree of fibrosis CRP in non-alcoholic fatty liver and non-alcoholic steatohepatitis: A systematic review and meta-analysis Antiinflammatory actions of GLP-1 medicines

Human clinical trials would be necessary to confirm this

Kumaran S, Panneerselvam KS, Shila S, Sivarajan K, Panneerselvam C: Age-associated deficit of mitochondrial oxidative phosphorylation in skeletal muscle: role of carnitine and lipoic acid

Through thoughtful deliberation of these elements paired with collaborative engagement with healthcare providers, individuals can identify the most suitable intervention to reach their wellness objectives

An open-label trial by Mansur et al 23 reported that addition of liraglutide 1.8 mg daily to the existing medication regimen led to significant increases from baseline to week 4 in the Trail-Making Test-B standard score and in a composite Z-score comprising multiple cognitive tests